Published July 30, 2023 | Version v1
Journal article Open

A primary hepatic lymphoma in a patient with Crohn's Disease receiving thiopurine and anti-TNF therapy: a case report.

  • 1. university of medicine of Tunis
  • 2. University of medicine of Tunis

Description

Primary Hepatic Lymphoma is a rare variant of non-Hodgkin's lymphoma with an incidence of 0.016% of all non-Hodgkin lymphomas. The most common histologic subtype is large diffuse B-cell lymphoma. Pathogenesis is not clearly established and undergoing immunosuppressive therapy has been proposed as a risk factor for primary hepatic lymphoma.

We report an intriguing case study, featuring a 23-year-old male patient with Crohn's Disease who had been receiving a combination therapy of thiopurine and anti-TNF for six years and was diagnosed with primary hepatic diffuse large B-cell lymphoma.

Files

Files (1.4 MB)

Name Size Download all
md5:07761981d664785e15737174ccd6efa8
1.4 MB Download